
Comparative Effect of Insulin Sensitizers and Statin on Metabolic Profile and Ultrasonographical Score in Non Alcoholic Fatty Liver Disease
Author(s) -
Himanshu Rana,
Suraj Singh Yadav,
Himanshu Reddy,
Shubham Singhal,
Dinesh Kumar Singh,
Kauser Usman
Publication year - 2016
Publication title -
journal of clinical and diagnostic research
Language(s) - English
Resource type - Journals
eISSN - 2249-782X
pISSN - 0973-709X
DOI - 10.7860/jcdr/2016/19887.8336
Subject(s) - medicine , fatty liver , metformin , rosuvastatin , gastroenterology , steatosis , lipid profile , pioglitazone , nonalcoholic fatty liver disease , endocrinology , type 2 diabetes , diabetes mellitus , insulin , disease , cholesterol
Non Alcoholic Fatty Liver Disease (NAFLD) is a metabolic disorder involving fat accumulation in the liver. The initial management for patients with NAFLD includes lifestyle modification and weight loss in overweight or obese patients.